BEAM Q3 2020 Earnings — Beam Therapeutics Inc. Revenue & Financial Results | Market Cap Arena

BEAMBeam Therapeutics Inc.

$3B

Q3 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$6,000+0.0% YoY

Gross Profit

-$30M-496983.3% margin

Operating Income

-$37M-622016.7% margin

Net Income

-$34M-574200.0% margin

EPS (Diluted)

$-0.69

QoQ Revenue Growth

+0.0%

Cash Flow

Operating Cash Flow

-$21M

Free Cash Flow

-$24M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$278M

Total Liabilities

$78M

Stockholders' Equity

$200M

Cash & Equivalents

$138M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$6,000	$6,000	+0.0%
Gross Profit	-$30M	-$13M	-137.8%
Operating Income	-$37M	-$18M	-107.1%
Net Income	-$34M	-$19M	-81.3%